[1]
|
Gromoll C, Karg A. Determination of the dose characteristics in the near area of a new type of 192Ir-HDR afterloading source with a pinpoint ionization chamber[J]. Phys Med Biol,2002, 47(6):875-887. |
[2]
|
Reynaert N, Van Eijkeren M, Taeymans Y, et al. Dosimetry of 192Ir sources used for endovascular brachytherapy[J]. Phys Med Biol, 2001, 46(2):499-516. |
[3]
|
Daskalov GM, Loffler E, Williamson JF. Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source[J].Med Phys, 1998, 25(11):2200-2208. |
[4]
|
Olsson S, Bergstrand ES, Carlsson AK, et al. Radiation dose measurements with alanine/agarose gel and thin alanine films around a 192Ir brachytherapy source, using ESR spectroscopy[J]. Phys Med Biol, 2002, 47(8):1333-1356. |
[5]
|
Brezovich IA, Duan J, Pareek PN, et al. In vivo urethral dose measurements:a method to verify high dose rate prostate treatments[J]. Med Phys, 2000, 27(10):2297-2301. |
[6]
|
Hood C, Duggan L, Bazley S, et al. LiF:Mg, Cu, P 'pin worms':miniature detectors for brachytherapy dosimetry[J].Radiat Prot Dosim, 2002, 101(4):407-410. |
[7]
|
Anagnostopoulos G, Baltas D, Geretschlaeger A, et al. In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CTbased planning for the treatment of prostate cancer[J].Int J Radiat Oncol Biol Phys, 2003,57(4):1183-1191. |
[8]
|
Huh S J, Lim DH, Ahn YC, et al. Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients[J]. Strahlenther Onkol,2003, 179(3):191-196. |
[9]
|
Pai S, Reinstein LE, Gluckman G, et al. The use of improved radiochromic film for in vivo quality assurance of high dose rate brachytherapy[J]. Med Phys, 1998, 25(7):1217-1221. |
[10]
|
Empesy JF, Low DA, Mutic S, et al. Validation of a precision radiochromic film dosimetry system for quantitative two-dimensional imageing of acute exposure dose distributions[J].Med Phys, 2000, 27(10):2462-2475. |
[11]
|
Nutsen BH, Skretting A, Hellebust TP, et al. Determination of 3D dose distribution from intracavitary brachytherapy of cervical cancer by MRI of irradiated ferrous sulphate gel[J].Radiother Oncol, 1997, 43(2):219-227. |
[12]
|
Scherer J, Bogner L, Herbst M. The verification of optimized 3D-dosage distributions with an MR Fricke gel[J]. Strahlenther Onkol, 1997, 173(1):36-42. |
[13]
|
Calmet C, Vincensini D, Bonnet J, et al. MRI dosimetry:a fast quantitative MRI method to determine 3D absorbed dose distributions[J]. Invest Radiol, 1999, 34(3):236-241. |
[14]
|
Silva NA, Nicolucci P, Baffa O. Spatial resolution of magnetic resonance imaging Fricke-gel dosimetry is improved with a honeycomb phantom[J]. Med Phys, 2003, 30(1):17-20. |
[15]
|
Mather ML, Baldock C. Ultrasound tomography imaging of radiation dose distributions in polymer gel dosimeters:preliminary study[J]. Med Phys, 2003, 30(8):2140-2148. |
[16]
|
Kipouros P, Pappas E, Baras P, et al. Wide dynamic dose range of VIPAR polymer gel dosimetry[J]. Phys Med Biol,2001, 46(8):2143-2159. |
[17]
|
Baras P, Seimenis I, Kipouros P, et al. Polymer gel dosimetry using a three-dimensional MRI acquisition technique[J].MedPhys, 2002, 29(11):2506-2516. |
[18]
|
Oldham M, Siewerdsen JH, Shetty A, et al. High resolution gel-dosimetry by optical-CT and MR scanning[J]. Med Phys,2001, 28(7):1436-1445. |
[19]
|
Pantelisl E, Papagiannis P, Anagnostopoulos G. Evaluation of a TG-43 compliant analytical dosimetry model in clinical 192Ir HDR brachytherapy treatment planning and assessment of the significance of source position and catheter reconstruction uncertainties[J].Phus Med Biol, 2004, 49(7):55-67. |
[20]
|
Datta NR, Basu R, Das KJ, et al. Problems in reporting doses and volumes during multiple high-dose-rate intracavitary brachytherapy for carcinoma cervix as per ICRU Report 38:a comparative study using flexible and rigid applicators[J].Gynecol Oncol, 2003,91(2):285-292. |